Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
NCT ID: NCT03638856
Last Updated: 2020-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2018-09-30
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hysteroscopy and Misoprostol Project
NCT00363389
Oral Misoprostol for Cervical Priming Before Hysteroscopy
NCT02159911
A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination
NCT00310921
Misoprostol For Nulliparous Women Before Hysteroscopy
NCT01156948
Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to Hysteroscopy
NCT00925938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Misoprostal group
Patients were added oral Misoprostal 200 mcg 2 tab per oral 3 hour before hysteroscopy
Misoprostol 200Mcg Tab
patient takes 2 tab of 200 mcg of Misoprostal 3 hr before hysteroscopy
Placebo group
Patients were take placebo 2 tab per oral 3 hour before hysteroscopy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol 200Mcg Tab
patient takes 2 tab of 200 mcg of Misoprostal 3 hr before hysteroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients have following indication for diagnosis hysteroscopy
* Abnormal uterine bleeding
* Unexplained infertility
* Recurrent pregnancy loss
* Chronic pelvic pain
* Late postpartum hemorrhage
3. Patients provided written informed consent
Exclusion Criteria
2. Patients who have contraindication for Misoprostal as following
* Allergic to Misoprostal
* Medical illnesses such as cardiovascular diseases, Asthma, Renal disease
3. Patients who have contraindication for Hysteroscopoy as following
* Pregnant women
* Pelvic inflammatory disease
* Infection at cervix and vagina
* Cervical cancer
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Medical Services Ministry of Public Health of Thailand
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rajavithi Hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rjcyto2531
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.